Under the leadership of Luis H. Camacho, MD, St. Luke’s Episcopal Hospital (SLEH) recently opened its new Oncology Medical Clinic to provide evaluation and treatment of medical oncology and blood disorders.
“Dr. Camacho’s extensive expertise in the area of research will be a tremendous benefit to our oncology patients, as well as to the entire St. Luke’s Health System, as he monitors quality and advances clinical research initiatives,” says Margaret M. Van Bree, DrPH, Chief Executive Officer of St. Luke’s and Senior Vice President of St. Luke’s Episcopal Health System.
He also serves as Medical Director and Research Director for the Cancer Center at St. Luke’s, which in 2011 was once again awarded a three-year Accreditation with Commendation from the Commission on Cancer. He is a member of the American Society of Clinical Oncology Scientific Immunotherapy Committee and a member of the Special Projects Study Section of the National Cancer Institute. Dr. Camacho serves on the CanCare Medical Advisory Board and is a member of St. Luke’s Cancer Center committee and the Hematology/Oncology section. At the state level, he is a Director-at-large on the Board of Directors of the Texas Society of Clinical Oncology and holds an Alternate Delegate position on the HCMS Delegation of the Harris County Medical Society.
A member of the American Society of Clinical Oncology Scientific Immunotherapy committee and a member of the Special projects Study section of the National Cancer Institute, Dr. Camachoalso is a member of the CanCare Medical Advisory Board St. Luke’s Cancer Center committee, and the Hematology/Oncology Section. He has received federal and private peer-reviewed funding from the National Cancer Institute, the Cancer and Leukemia Group B, and the Goodwin Foundation.
Dr. Camacho received his medical degree from the Military School of Medicine in Bogota, Columbia and migrated to the United States in 1992 after completing his graduate training at the National Cancer Institute/Hospital Militar in Bogota. He received a master’s degree in Public Health from The George Washington University School of Public Health and Health Sciences. After completing his graduate training, he joined the Hematology/Medical Oncology fellowship program at Memorial Sloan-Kettering Cancer Center/Cornell University Medical College and trained with the Developmental Therapeutics Service until 2001, when he joined the faculty at The University of Texas MD Anderson Cancer Center. Before joining SLEH, he was a member of Oncology Consultants in Houston in 2007 as Director of the Department of Research.